Clinical Research Directory
Browse clinical research sites, groups, and studies.
Access to Genetic Testing in Underserved Patients With Cancer
Sponsor: University of Southern California
Summary
This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care. Multiple factors contribute to low usage of genetic testing but for many patients the lack of access to genetic counseling and testing is an important and flexible factor. Lack of access is especially relevant to racial/ethnic minority patients and those living in non-metropolitan rural settings who are frequently cared for at safety-net hospitals with limited genetics services. Alternative delivery models are necessary to improve rates of access to genetic testing in patients with cancer. Health information technology is under used by genetics providers. A patient-facing relational agent (PERLA) will provide pre-test genetics education in both English and Spanish across two clinical settings to facilitate more timely access to genetic testing. Using the PERLA intervention may help researchers learn different ways to provide education about genetic testing to patients with cancer compared to usual care.
Official title: Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
800
Start Date
2023-10-24
Completion Date
2028-10-24
Last Updated
2026-03-18
Healthy Volunteers
Yes
Conditions
Interventions
Best Practice
Receive provider-based genetic counseling
Educational Intervention
Receive genetics education
Electronic Health Record Review
Ancillary studies
Genetic Counseling
Receive provider-based genetic counseling
Interview
Ancillary studies
Survey Administration
Ancillary studies
Locations (2)
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States
University of Rochester
Rochester, New York, United States